The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions
Origa R;
2018-01-01
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.